Cardiology, Diabetes & Nephrology at the Limits London 2021

Cardiology, Diabetes & Nephrology at the Limits London
Monday, 12 April 2021 & Tuesday, 13 April 2021

Post Event Videos

Day 1 complete webcast Day 2 complete webcast
 
 

Industry Symposia

35 Years Since Brown & Goldstein Nobel Prize:
How is the Science of CV Risk Reduction Evolving?
Cardiorenal considerations for type 2 diabetes -
How to choose.
 
 

CDNATL Canada Presentations

The Lancet Lecture: 100 years of insulin - have we reached the limits?
Professor Bernard Zinman
University of Toronto, Canada

 
 

Controlling cardiovascular risk factors in 2021 - beyond glucose
Professor Lawrence Leiter
University of Toronto, Canada

Summary Version Full Version
 
 

The new genetics & therapies of dyslipidemias
Professor Robert A Hegele
Robarts Research Institute, Ontario, Canada

Summary Version Full Version
 
 

Cardiac atheroma at the limits - are we fighting the final battle?
Professor Peter Libby
Brigham and Women's Hospital, Harvard Medical School, Boston, USA

Summary Version Full Version
 
 

Primordial cardiology in youth - what are the limits?
Professor John Deanfield
University College London, UK

Summary Version Full Version
 
 

Cardiovascular mechanisms of GLP-1 and its emerging co-agonist partners
Professor Daniel Drucker
University of Toronto, Canada

Summary Version Full Version
 
 

Clinical benefit of modern therapy for type 2 diabetes - GLP-1 analogues
Professor Mansoor Husain
University of Toronto, Canada

Summary Version Full Version
 
 

The science of obesity, where might this lead clinical practice?
Professor Sean Wharton
McMaster University, Canada

Summary Version Full Version
 
 

SGLT2i Cardiorenal mechanisms in diabetes and beyond
Professor Julie Lovshin
University of Toronto, Canada

Summary Version Full Version
 
 

Heart failure therapy - extending the limits!
Professor Theresa McDonagh
King' s College London, UK

Summary Version Full Version
 
 

Surprising findings from clinical trials - cardiology, diabetes & nephrology
Professor Marc Pfeffer
Harvard University, Boston, USA

 
 

Support

CDNATL London 2021 is financially supported by the Pharmaceutical Industry and Academia. The Pharmaceutical Industry’s financial support for the event is restricted primarily to facilitating the development of the independent medical/scientific content and speaker fees. Funds from the Pharmaceutical Industry have not been used for travel, accommodation or any other ancillary expenses for participants. Supporters have had no input into the content of the independent scientific sessions or any other aspect of the meeting. Supporters are listed here.